- Home
- RUN vs NNNN Comparison
RUN vs NNNN Comparison
Compare RUN & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RUN
- NNNN
- Stock Information
- Founded
- RUN 2007
- NNNN 2021
- Country
- RUN United States
- NNNN Germany
- Employees
- RUN N/A
- NNNN N/A
- Industry
- RUN Industrial Machinery/Components
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RUN Miscellaneous
- NNNN Health Care
- Exchange
- RUN Nasdaq
- NNNN Nasdaq
- Market Cap
- RUN 2.4B
- NNNN 2.2B
- IPO Year
- RUN 2015
- NNNN 2025
- Fundamental
- Price
- RUN $10.78
- NNNN $50.62
- Analyst Decision
- RUN Buy
- NNNN
- Analyst Count
- RUN 22
- NNNN 0
- Target Price
- RUN $14.78
- NNNN N/A
- AVG Volume (30 Days)
- RUN 20.4M
- NNNN 166.7K
- Earning Date
- RUN 08-06-2025
- NNNN 01-01-0001
- Dividend Yield
- RUN N/A
- NNNN N/A
- EPS Growth
- RUN N/A
- NNNN N/A
- EPS
- RUN N/A
- NNNN 0.06
- Revenue
- RUN $2,083,802,000.00
- NNNN $8,185,146.00
- Revenue This Year
- RUN $10.96
- NNNN N/A
- Revenue Next Year
- RUN $10.92
- NNNN N/A
- P/E Ratio
- RUN N/A
- NNNN $899.52
- Revenue Growth
- RUN N/A
- NNNN 21.95
- 52 Week Low
- RUN $5.38
- NNNN $5.18
- 52 Week High
- RUN $22.26
- NNNN $55.65
- Technical
- Relative Strength Index (RSI)
- RUN 57.90
- NNNN N/A
- Support Level
- RUN $10.32
- NNNN N/A
- Resistance Level
- RUN $11.88
- NNNN N/A
- Average True Range (ATR)
- RUN 0.81
- NNNN 0.00
- MACD
- RUN 0.01
- NNNN 0.00
- Stochastic Oscillator
- RUN 51.54
- NNNN 0.00
About RUN Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.